Skip to search formSkip to main contentSkip to account menu

drug intolerance

Known as: drugs intolerance 
National Institutes of Health

Related topics

Related topics

1 relation
Drug resistance

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
2015
2015
Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
SETTING Rifampicin (RMP) has been reported to reduce moxifloxacin (MFX) levels, which may interfere with the effectiveness of MFX… 
Review
2011
Review
2011
Managing resistance in chronic myeloid leukemia.
Review
2010
Review
2010
Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib.
2004
2004
Open randomized study of pyrimethamine–sulphadoxine vs. pyrimethamine–sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children
Background  Increasing drug resistance in Plasmodium falciparum has necessitated renewed search for cheap, effective alternatives… 
Highly Cited
2003
Highly Cited
2003
Determination of bleeding risk using genetic markers in patients taking phenprocoumon
BackgroundIn patients on oral anticoagulation with warfarin, genetic variations of the cytochrome P 450–CYP2C9 have recently been… 
Review
2002
Review
2002
The Role of Protease Inhibitor Therapy in Children with HIV Infection
In comparison with HIV infection in adults, higher HIV RNA levels in children with perinatal HIV infection, differences in the… 
Review
1999
Review
1999
Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
Highly Cited
1979
Highly Cited
1979
Timolol maleate: efficacy and safety.
A randomized, double-masked trial of various concentrations of timolol maleate ophthalmic solution (0.1%, 0.25%, 0.5%, and 1.0… 
1964
1964
TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)